Upload
priscilla-atkins
View
220
Download
2
Tags:
Embed Size (px)
Citation preview
The Microbiome and Probiotics:Fact and Fiction
Ameet Parikh, MD
Human Gut microbiome
- What is it- What role does it play in health and in disease- Modification of the microbiome to maintainhealth or treat disease
Microbiome
Microbiota • The microorganisms that live in an established environment
Microbiome• The full complement of microbes, their genes, and genomes in a particular environment
Microbiome
The Gut Microbiota
- Complex community of microbes – estimated to contain 200 trillion cells
- > 1000 diverse microbial species
- 10 x the number of human cells in our body
- Gut microbiome is 150 x larger than the human genome
Gut Microbiota
Gut Microbiota
Bacteroidetes and Firmicutes make up around 90% ofthe gut microbiota
Each individual harbors his/her own distinctivepattern of gut microbial communities
For a given individual, the fecal microbiota remainsremarkably stable over a person’s lifetime
Prevents colonization by pathogens“Educates the immune system”Metabolic role- Caloric salvage- Produces• SCFA• Vit K and folateParticipates in drug metabolism• Activates 5-ASADeconjugates bile acids
Gut Microbiota - Functions
Gut Microbiota
Colonization of the gastrointestinal tract begins immediately after birth
Initial bacterial colonization (normal) starts from a “Germ free” intrauterine environment and is populated through maternal vaginal/fecal flora and oral feeding (breast milk vs formula)
Complete adult colonization : by 3 yrs of life
Factors affecting Gut Microbiome
Alterations in gut microbiota have been linked with
FBD Metabolic diseasesIBD ObesityCDI MalignancyCeliac disease Type I DMAllergies NASHAutism Depression
Microbiome
Does the intestinal microbiota differ in patientswith specific disorders (IBS/IBD) from healthysubjects?
If the microbiota does differ, is it an importantfactor in the pathogenesis of the disorder?
Gut Microbiota
Gut Microbiota - IBD
Pathogenesis – linked to inappropriate activation of GI immune system toward the gut microbiota in geneticallysusceptible hosts &under the influence of environmentalfactors
Gut Microbiota - IBD
IBS, functional bloating/constipation/diarrhea
Change in gut microbiota – cause abn fermentation ofdietary substrates
elicit excess stimulation of the mucosal immune systemthrough a ‘leaky gut’ – leads to low grade inflammation,affects gut motor responses & elicits visceralhypersensitivity
Decreased Bifidobacterium and Lactobacillus in IBS
Gut Microbiota - FBD
Gut Microbiota - CDI
- Diet- Antibiotics- Prebiotics- Probiotics- Symbiotics- FMT
Gut Microbiota
Global sales of Probiotics – 21.6 billion dollarsin 2010, expected to reach 31.1 billion in 2015
Fastest growing segment of the global dietarysupplement & functional food industries
People are looking for ‘natural’ or non-drugways to maintain health or treat disease
Probiotics
Probiotics
First described by Metchnikoff in 1907
Probiotics
Probiotics Live microorganisms which, when administered in adequate amounts, confer a health benefit on the host
Prebiotics Nondigestible substances that provide a beneficial physiological effect for the host by selectively stimulating the favorable growth or activity of a limited number of indigenous bacteria
Probiotics
Synbiotics
Products that contain both probiotics and prebiotics
Probiotics in the Treatment of Gastrointestinal DisordersDiarrhea
Acute infectiousAntibiotic-associated C. difficile
Lactose Intolerance
FBD
IBDUlcerative colitisCrohn’s diseasePouchitis
H. pylori Eradication
Probiotics
• Able to survive the passage through the digestive system.• Able to attach to the intestinal epithelia and colonize.• Able to maintain good viability.• Able to utilize the nutrients and substrates in a normal diet.• Non pathogenic and non toxic.• Capable of exerting a beneficial effect on the host.• Stability of desired characteristics during processing, storage and transportation.
Characteristics of Effective Probiotics
Probiotics – Diarrheal Diseases
Probiotics - AAD
Antibiotic Associated Diarrhea
Antibiotic Associated Diarrhea
Antibiotic Associated Diarrhea
Probiotics - FBD
10 – 15% of population has IBS
pathogenesis – dysmotility, visc hypersensitivity, disturbances in GI flora, and chronic immune activationleading to low grade mucosal inflammation have all been implicated
Probiotics - CDAD
• First Transplant was in November 2013
• Performed 62 transplants to date for recurrent CDI
• Of the elective cases we have had sustained cures in 57/62 first time FMT- 5 relapses occurred
• 3/5 relapses needed antibiotics after FMT
• 3 competed 2nd FMT, no continued issues to date
• 2 treated with Vanco or Dificid and did not require 2nd FMT
FMT – LGI experience
Probiotics - IBD
FMT - IBD
FMT - IBD
FMT - IBD
Much work remains:
• Is FMT effective and safe in IBD?- Adequately powered trials
• Ideal recipient?- Genotype- Phenotype: Pouchitis, Proctitis, Post-op prophylaxis,ileal Crohn’s, maintenance of remission, Microbiome- Concomitant meds- Can FMT make some patients worse?
Great success story for recurrent CDI
Being studied for multiple other conditions – IBD, IBS, ObesityAutism, NASH/Met synd, reversal of multidrug resistance to abx
IBD is associated with dysbiosis–More complicated than C. difficile
Patients are eager for alternative therapies
FMT appears generally “pretty safe”– Infections and disease flares have been reported
Therapeutic Manipulation of gut microbiota holds promise & mayeventually prove beneficial for other conditions– We must not be overly enthusiastic and remember that this isexperimental and unproven therapy.
FMT
Lachnospiraceae family
Faecalibacterium prausnitzii
Akkermansia muciniphila
Probiotic ecosystems
Microbiome - Future
“All disease begins in the gut”Hippocrates 460 BC – 370BC
“Health is determined by the microbiota in ourgut”
Hippocrates
Gut Microbiome
Gut Microbiome
Thank You